Navigation Links
NexGen Biomedical, Inc. Provides New Insights Into Jett Travolta's Seizure Related Death
Date:6/12/2012

SAN JOSE, Calif., June 12, 2012 /PRNewswire/ -- US patent 8,197,858 issued on June 12, 2012 discloses a previously unknown pathogenesis underlying seizures / epilepsy and migraines and provides novel treatment options for the 50 million seizure patients and 300 million migraine sufferers worldwide.

"We scientifically validated that triggers such as drops in estrogen or testosterone or increases in prostaglandin or Vitamin D synthesis all boost release of calcium ions from bone.  We also validated that boosting extracellular calcium ion levels boosts seizure and migraine risk by 1) depolarizing nerve membranes, 2) increasing calcium channel mediated neurotransmitter release and 3) boosting muscle contractility,"  according to Mark Zamoyski,  NexGen Biomedical, Inc.'s founder and the patent holder.

"Why 50 million people worldwide have low seizures thresholds is not clear, however, the new pathogenesis provides an insight into factors that would increase their risk of having a seizure,"  continued Mark Zamoyski.  "We can begin to understand the perfect storm of risk factors that possibly contributed to 16 year old Jett Travolta's uncontrollable seizure while on a vacation in the Bahamas.  Puberty brings nighttime testosterone surges, followed by daytime drops, which boost calcium ion release from bone.   Sun exposure can boost Vitamin D synthesis to 25 times the RDA and sunburn boosts prostaglandin synthesis, both of which boost release of calcium from bone and hence boost seizure risk.  And those are just some of the risk factors on the list."

"Previously unexplained migraine observations could now also be explained. As an example, one study found 45% of women with menstrual migraines had magnesium deficiency.  The new pathogenesis explanation:  It is known that estrogen levels drop precipitously at the start of menstruation.  That in turn would result in a boost in extracellular calcium levels.   Magnesium is a physiological calcium channel blocker, which would attenuate the calcium channel mediated neurotransmitter release."

"Basically, the science indicates that anything that boosts release of calcium ions from bone boosts seizure and migraine risk and conversely anything that reduces release of calcium ions from bone reduces seizure and migraine risk.  Fortunately, there are existing bone homeostasis drugs that could be easily repurposed to reduce seizure and migraine risk,"  Mark Zamoyski summarized.

More comprehensive data supporting the pathogenesis, and a list of things that increase or decrease release of calcium ions from bone, is provided at www.nexgen.biz.


'/>"/>
SOURCE NexGen Biomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
2. Elevate Provides Remote Access to Personal Health Records Using MyMedicalRecords.com
3. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
4. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
7. Endo Announces Resolution of Patent Litigation with Watson Pharmaceuticals Related to Lidoderm®
8. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
9. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
10. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
11. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading healthcare data analytics ... 2017 ranking of the Best-Equipped Hospitals in Latin America ... GHI,s hospitals database for Latin America , which is ... database covers 86% of the hospitals in Latin ... each institution in key areas such as beds, medical specialties, ...
(Date:5/9/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... has earned a spot on Forbes, "America,s ... ranked among 500 U.S. employers as well as in ... Services. The annual Forbes rankings ... of over 30,000 employees across 25 industries. The survey ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Rob Lowe acts as ... production of the series is on hiking in American. Viewers can reconnect with America ... great benefits of hiking. , Many consumers have looked for an inventive new place ...
(Date:5/26/2017)... ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the personal journey of ... Cross” is the creation of published authors, Bob and Margaret Massey. Bob Massey is ... is "panther quick and leather tough." His love for others is apparent in all ...
(Date:5/26/2017)... ... ... Jack: Against All Odds”: the story of Coach Cactus Jack and the impact he ... creation of published author, Walter Hubbard, a retired wildlife and fisheries biologist and pharmacy ... Walter and Jane have three adult children and a granddaughter. Walter and ...
(Date:5/24/2017)... ... May 24, 2017 , ... In ... choosing the most appropriate instruments for research and understanding the basic principles that ... webinar will focus on innovations in stereo microscopy for brightfield and fluorescence typically ...
(Date:5/24/2017)... California (PRWEB) , ... May 24, 2017 , ... ... through innovative medical image management and interpretation, has received U.S. Food and Drug ... , Nucleus.io is a web-based, scalable and secure cloud platform for medical image ...
Breaking Medicine News(10 mins):